Quality of life among patients post-myocardial infarction at baseline in the Survival and Ventricular Enlargement (SAVE) trial
Abstract A quality of life ancillary study was incorporated into the Survival and Ventricular Enlargement (SAVE) trial of captopril versus placebo among patients who survived an acute myocardial infarction with compromised ventricular functioning, but no overt heart failure. Assessments included pat...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
1994 |
|---|
| Umfang: |
9 |
|---|
| Reproduktion: |
Springer Online Journal Archives 1860-2002 |
|---|---|
| Übergeordnetes Werk: |
in: Quality of life research - 1992, 3(1994) vom: Feb., Seite 111-119 |
| Übergeordnetes Werk: |
volume:3 ; year:1994 ; month:02 ; pages:111-119 ; extent:9 |
| Links: |
|---|
| Katalog-ID: |
NLEJ195670523 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLEJ195670523 | ||
| 003 | DE-627 | ||
| 005 | 20230506164050.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 070526s1994 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)NLEJ195670523 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 245 | 1 | 0 | |a Quality of life among patients post-myocardial infarction at baseline in the Survival and Ventricular Enlargement (SAVE) trial |
| 264 | 1 | |c 1994 | |
| 300 | |a 9 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Abstract A quality of life ancillary study was incorporated into the Survival and Ventricular Enlargement (SAVE) trial of captopril versus placebo among patients who survived an acute myocardial infarction with compromised ventricular functioning, but no overt heart failure. Assessments included patient symptoms, health perceptions, emotional, cognitive, social and sexual levels of functloning, as well as potential covariates, such as life events and social support. The purpose of this study was to evaluate the psychometric properties of the quality of life measures in the SAVE at baseline, and provide a pre-randomization profile of the SAVE patients. One hundred and eighty-four patients participated in this aspect of the trial. Reliability alpha coefficlents were adequate or better for all questionnaires, except for life events and sexual activities. Consistent with prior studies, the quality of life parameters were uncorrelated with ventricular ejection fraction. Despite experiencing a recent myocardial infarction with compromised ventricular functioning, patients at baseline generally nelther appeared depressed nor focused on symptoms. The baseline findings support the inclusion of the quality of life ancillary study in the overall SAVE trial because of the independent contribution likely to be achieved in terms of evaluating both disease progression and treatment efficacy. | ||
| 533 | |f Springer Online Journal Archives 1860-2002 | ||
| 700 | 1 | |a Gorkin, L. |4 oth | |
| 700 | 1 | |a Follick, M. J. |4 oth | |
| 700 | 1 | |a Geltman, E. |4 oth | |
| 700 | 1 | |a Hamm, P. |4 oth | |
| 700 | 1 | |a Sollano, J. S. |4 oth | |
| 700 | 1 | |a Sylvia, S. |4 oth | |
| 700 | 1 | |a Jacobson, K. |4 oth | |
| 700 | 1 | |a Jacobson, M. J. |4 oth | |
| 700 | 1 | |a Cochrane, B. S. |4 oth | |
| 700 | 1 | |a Sussex, B. |4 oth | |
| 700 | 1 | |a Klein, M. |4 oth | |
| 700 | 1 | |a Gaudette, G. |4 oth | |
| 700 | 1 | |a Goldman, D. |4 oth | |
| 700 | 1 | |a Carrol, D. |4 oth | |
| 700 | 1 | |a Holcombe, R. |4 oth | |
| 700 | 1 | |a Abern, D. K. |4 oth | |
| 773 | 0 | 8 | |i in |t Quality of life research |d 1992 |g 3(1994) vom: Feb., Seite 111-119 |w (DE-627)NLEJ188989161 |w (DE-600)2008960-0 |x 1573-2649 |7 nnns |
| 773 | 1 | 8 | |g volume:3 |g year:1994 |g month:02 |g pages:111-119 |g extent:9 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/BF00435254 |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a ZDB-1-SOJ | ||
| 912 | |a GBV_NL_ARTICLE | ||
| 951 | |a AR | ||
| 952 | |d 3 |j 1994 |c 2 |h 111-119 |g 9 | ||
| matchkey_str |
article:15732649:1994----::ultolfaogainsotycrilnacintaeienhsriaade |
|---|---|
| hierarchy_sort_str |
1994 |
| publishDate |
1994 |
| allfields |
(DE-627)NLEJ195670523 DE-627 ger DE-627 rakwb eng Quality of life among patients post-myocardial infarction at baseline in the Survival and Ventricular Enlargement (SAVE) trial 1994 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract A quality of life ancillary study was incorporated into the Survival and Ventricular Enlargement (SAVE) trial of captopril versus placebo among patients who survived an acute myocardial infarction with compromised ventricular functioning, but no overt heart failure. Assessments included patient symptoms, health perceptions, emotional, cognitive, social and sexual levels of functloning, as well as potential covariates, such as life events and social support. The purpose of this study was to evaluate the psychometric properties of the quality of life measures in the SAVE at baseline, and provide a pre-randomization profile of the SAVE patients. One hundred and eighty-four patients participated in this aspect of the trial. Reliability alpha coefficlents were adequate or better for all questionnaires, except for life events and sexual activities. Consistent with prior studies, the quality of life parameters were uncorrelated with ventricular ejection fraction. Despite experiencing a recent myocardial infarction with compromised ventricular functioning, patients at baseline generally nelther appeared depressed nor focused on symptoms. The baseline findings support the inclusion of the quality of life ancillary study in the overall SAVE trial because of the independent contribution likely to be achieved in terms of evaluating both disease progression and treatment efficacy. Springer Online Journal Archives 1860-2002 Gorkin, L. oth Follick, M. J. oth Geltman, E. oth Hamm, P. oth Sollano, J. S. oth Sylvia, S. oth Jacobson, K. oth Jacobson, M. J. oth Cochrane, B. S. oth Sussex, B. oth Klein, M. oth Gaudette, G. oth Goldman, D. oth Carrol, D. oth Holcombe, R. oth Abern, D. K. oth in Quality of life research 1992 3(1994) vom: Feb., Seite 111-119 (DE-627)NLEJ188989161 (DE-600)2008960-0 1573-2649 nnns volume:3 year:1994 month:02 pages:111-119 extent:9 http://dx.doi.org/10.1007/BF00435254 GBV_USEFLAG_U ZDB-1-SOJ GBV_NL_ARTICLE AR 3 1994 2 111-119 9 |
| spelling |
(DE-627)NLEJ195670523 DE-627 ger DE-627 rakwb eng Quality of life among patients post-myocardial infarction at baseline in the Survival and Ventricular Enlargement (SAVE) trial 1994 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract A quality of life ancillary study was incorporated into the Survival and Ventricular Enlargement (SAVE) trial of captopril versus placebo among patients who survived an acute myocardial infarction with compromised ventricular functioning, but no overt heart failure. Assessments included patient symptoms, health perceptions, emotional, cognitive, social and sexual levels of functloning, as well as potential covariates, such as life events and social support. The purpose of this study was to evaluate the psychometric properties of the quality of life measures in the SAVE at baseline, and provide a pre-randomization profile of the SAVE patients. One hundred and eighty-four patients participated in this aspect of the trial. Reliability alpha coefficlents were adequate or better for all questionnaires, except for life events and sexual activities. Consistent with prior studies, the quality of life parameters were uncorrelated with ventricular ejection fraction. Despite experiencing a recent myocardial infarction with compromised ventricular functioning, patients at baseline generally nelther appeared depressed nor focused on symptoms. The baseline findings support the inclusion of the quality of life ancillary study in the overall SAVE trial because of the independent contribution likely to be achieved in terms of evaluating both disease progression and treatment efficacy. Springer Online Journal Archives 1860-2002 Gorkin, L. oth Follick, M. J. oth Geltman, E. oth Hamm, P. oth Sollano, J. S. oth Sylvia, S. oth Jacobson, K. oth Jacobson, M. J. oth Cochrane, B. S. oth Sussex, B. oth Klein, M. oth Gaudette, G. oth Goldman, D. oth Carrol, D. oth Holcombe, R. oth Abern, D. K. oth in Quality of life research 1992 3(1994) vom: Feb., Seite 111-119 (DE-627)NLEJ188989161 (DE-600)2008960-0 1573-2649 nnns volume:3 year:1994 month:02 pages:111-119 extent:9 http://dx.doi.org/10.1007/BF00435254 GBV_USEFLAG_U ZDB-1-SOJ GBV_NL_ARTICLE AR 3 1994 2 111-119 9 |
| allfields_unstemmed |
(DE-627)NLEJ195670523 DE-627 ger DE-627 rakwb eng Quality of life among patients post-myocardial infarction at baseline in the Survival and Ventricular Enlargement (SAVE) trial 1994 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract A quality of life ancillary study was incorporated into the Survival and Ventricular Enlargement (SAVE) trial of captopril versus placebo among patients who survived an acute myocardial infarction with compromised ventricular functioning, but no overt heart failure. Assessments included patient symptoms, health perceptions, emotional, cognitive, social and sexual levels of functloning, as well as potential covariates, such as life events and social support. The purpose of this study was to evaluate the psychometric properties of the quality of life measures in the SAVE at baseline, and provide a pre-randomization profile of the SAVE patients. One hundred and eighty-four patients participated in this aspect of the trial. Reliability alpha coefficlents were adequate or better for all questionnaires, except for life events and sexual activities. Consistent with prior studies, the quality of life parameters were uncorrelated with ventricular ejection fraction. Despite experiencing a recent myocardial infarction with compromised ventricular functioning, patients at baseline generally nelther appeared depressed nor focused on symptoms. The baseline findings support the inclusion of the quality of life ancillary study in the overall SAVE trial because of the independent contribution likely to be achieved in terms of evaluating both disease progression and treatment efficacy. Springer Online Journal Archives 1860-2002 Gorkin, L. oth Follick, M. J. oth Geltman, E. oth Hamm, P. oth Sollano, J. S. oth Sylvia, S. oth Jacobson, K. oth Jacobson, M. J. oth Cochrane, B. S. oth Sussex, B. oth Klein, M. oth Gaudette, G. oth Goldman, D. oth Carrol, D. oth Holcombe, R. oth Abern, D. K. oth in Quality of life research 1992 3(1994) vom: Feb., Seite 111-119 (DE-627)NLEJ188989161 (DE-600)2008960-0 1573-2649 nnns volume:3 year:1994 month:02 pages:111-119 extent:9 http://dx.doi.org/10.1007/BF00435254 GBV_USEFLAG_U ZDB-1-SOJ GBV_NL_ARTICLE AR 3 1994 2 111-119 9 |
| allfieldsGer |
(DE-627)NLEJ195670523 DE-627 ger DE-627 rakwb eng Quality of life among patients post-myocardial infarction at baseline in the Survival and Ventricular Enlargement (SAVE) trial 1994 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract A quality of life ancillary study was incorporated into the Survival and Ventricular Enlargement (SAVE) trial of captopril versus placebo among patients who survived an acute myocardial infarction with compromised ventricular functioning, but no overt heart failure. Assessments included patient symptoms, health perceptions, emotional, cognitive, social and sexual levels of functloning, as well as potential covariates, such as life events and social support. The purpose of this study was to evaluate the psychometric properties of the quality of life measures in the SAVE at baseline, and provide a pre-randomization profile of the SAVE patients. One hundred and eighty-four patients participated in this aspect of the trial. Reliability alpha coefficlents were adequate or better for all questionnaires, except for life events and sexual activities. Consistent with prior studies, the quality of life parameters were uncorrelated with ventricular ejection fraction. Despite experiencing a recent myocardial infarction with compromised ventricular functioning, patients at baseline generally nelther appeared depressed nor focused on symptoms. The baseline findings support the inclusion of the quality of life ancillary study in the overall SAVE trial because of the independent contribution likely to be achieved in terms of evaluating both disease progression and treatment efficacy. Springer Online Journal Archives 1860-2002 Gorkin, L. oth Follick, M. J. oth Geltman, E. oth Hamm, P. oth Sollano, J. S. oth Sylvia, S. oth Jacobson, K. oth Jacobson, M. J. oth Cochrane, B. S. oth Sussex, B. oth Klein, M. oth Gaudette, G. oth Goldman, D. oth Carrol, D. oth Holcombe, R. oth Abern, D. K. oth in Quality of life research 1992 3(1994) vom: Feb., Seite 111-119 (DE-627)NLEJ188989161 (DE-600)2008960-0 1573-2649 nnns volume:3 year:1994 month:02 pages:111-119 extent:9 http://dx.doi.org/10.1007/BF00435254 GBV_USEFLAG_U ZDB-1-SOJ GBV_NL_ARTICLE AR 3 1994 2 111-119 9 |
| allfieldsSound |
(DE-627)NLEJ195670523 DE-627 ger DE-627 rakwb eng Quality of life among patients post-myocardial infarction at baseline in the Survival and Ventricular Enlargement (SAVE) trial 1994 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract A quality of life ancillary study was incorporated into the Survival and Ventricular Enlargement (SAVE) trial of captopril versus placebo among patients who survived an acute myocardial infarction with compromised ventricular functioning, but no overt heart failure. Assessments included patient symptoms, health perceptions, emotional, cognitive, social and sexual levels of functloning, as well as potential covariates, such as life events and social support. The purpose of this study was to evaluate the psychometric properties of the quality of life measures in the SAVE at baseline, and provide a pre-randomization profile of the SAVE patients. One hundred and eighty-four patients participated in this aspect of the trial. Reliability alpha coefficlents were adequate or better for all questionnaires, except for life events and sexual activities. Consistent with prior studies, the quality of life parameters were uncorrelated with ventricular ejection fraction. Despite experiencing a recent myocardial infarction with compromised ventricular functioning, patients at baseline generally nelther appeared depressed nor focused on symptoms. The baseline findings support the inclusion of the quality of life ancillary study in the overall SAVE trial because of the independent contribution likely to be achieved in terms of evaluating both disease progression and treatment efficacy. Springer Online Journal Archives 1860-2002 Gorkin, L. oth Follick, M. J. oth Geltman, E. oth Hamm, P. oth Sollano, J. S. oth Sylvia, S. oth Jacobson, K. oth Jacobson, M. J. oth Cochrane, B. S. oth Sussex, B. oth Klein, M. oth Gaudette, G. oth Goldman, D. oth Carrol, D. oth Holcombe, R. oth Abern, D. K. oth in Quality of life research 1992 3(1994) vom: Feb., Seite 111-119 (DE-627)NLEJ188989161 (DE-600)2008960-0 1573-2649 nnns volume:3 year:1994 month:02 pages:111-119 extent:9 http://dx.doi.org/10.1007/BF00435254 GBV_USEFLAG_U ZDB-1-SOJ GBV_NL_ARTICLE AR 3 1994 2 111-119 9 |
| language |
English |
| source |
in Quality of life research 3(1994) vom: Feb., Seite 111-119 volume:3 year:1994 month:02 pages:111-119 extent:9 |
| sourceStr |
in Quality of life research 3(1994) vom: Feb., Seite 111-119 volume:3 year:1994 month:02 pages:111-119 extent:9 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| isfreeaccess_bool |
false |
| container_title |
Quality of life research |
| authorswithroles_txt_mv |
Gorkin, L. @@oth@@ Follick, M. J. @@oth@@ Geltman, E. @@oth@@ Hamm, P. @@oth@@ Sollano, J. S. @@oth@@ Sylvia, S. @@oth@@ Jacobson, K. @@oth@@ Jacobson, M. J. @@oth@@ Cochrane, B. S. @@oth@@ Sussex, B. @@oth@@ Klein, M. @@oth@@ Gaudette, G. @@oth@@ Goldman, D. @@oth@@ Carrol, D. @@oth@@ Holcombe, R. @@oth@@ Abern, D. K. @@oth@@ |
| publishDateDaySort_date |
1994-02-01T00:00:00Z |
| hierarchy_top_id |
NLEJ188989161 |
| id |
NLEJ195670523 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ195670523</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230506164050.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">070526s1994 xx |||||o 00| ||eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ195670523</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Quality of life among patients post-myocardial infarction at baseline in the Survival and Ventricular Enlargement (SAVE) trial</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1994</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract A quality of life ancillary study was incorporated into the Survival and Ventricular Enlargement (SAVE) trial of captopril versus placebo among patients who survived an acute myocardial infarction with compromised ventricular functioning, but no overt heart failure. Assessments included patient symptoms, health perceptions, emotional, cognitive, social and sexual levels of functloning, as well as potential covariates, such as life events and social support. The purpose of this study was to evaluate the psychometric properties of the quality of life measures in the SAVE at baseline, and provide a pre-randomization profile of the SAVE patients. One hundred and eighty-four patients participated in this aspect of the trial. Reliability alpha coefficlents were adequate or better for all questionnaires, except for life events and sexual activities. Consistent with prior studies, the quality of life parameters were uncorrelated with ventricular ejection fraction. Despite experiencing a recent myocardial infarction with compromised ventricular functioning, patients at baseline generally nelther appeared depressed nor focused on symptoms. The baseline findings support the inclusion of the quality of life ancillary study in the overall SAVE trial because of the independent contribution likely to be achieved in terms of evaluating both disease progression and treatment efficacy.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="f">Springer Online Journal Archives 1860-2002</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gorkin, L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Follick, M. J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Geltman, E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hamm, P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sollano, J. S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sylvia, S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jacobson, K.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jacobson, M. J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cochrane, B. S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sussex, B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Klein, M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gaudette, G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Goldman, D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Carrol, D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Holcombe, R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Abern, D. K.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">in</subfield><subfield code="t">Quality of life research</subfield><subfield code="d">1992</subfield><subfield code="g">3(1994) vom: Feb., Seite 111-119</subfield><subfield code="w">(DE-627)NLEJ188989161</subfield><subfield code="w">(DE-600)2008960-0</subfield><subfield code="x">1573-2649</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:3</subfield><subfield code="g">year:1994</subfield><subfield code="g">month:02</subfield><subfield code="g">pages:111-119</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1007/BF00435254</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-SOJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">3</subfield><subfield code="j">1994</subfield><subfield code="c">2</subfield><subfield code="h">111-119</subfield><subfield code="g">9</subfield></datafield></record></collection>
|
| series2 |
Springer Online Journal Archives 1860-2002 |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)NLEJ188989161 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| collection |
NL |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
1573-2649 |
| topic_title |
Quality of life among patients post-myocardial infarction at baseline in the Survival and Ventricular Enlargement (SAVE) trial |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
l g lg m j f mj mjf e g eg p h ph j s s js jss s s ss k j kj m j j mj mjj b s c bs bsc b s bs m k mk g g gg d g dg d c dc r h rh d k a dk dka |
| hierarchy_parent_title |
Quality of life research |
| hierarchy_parent_id |
NLEJ188989161 |
| hierarchy_top_title |
Quality of life research |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)NLEJ188989161 (DE-600)2008960-0 |
| title |
Quality of life among patients post-myocardial infarction at baseline in the Survival and Ventricular Enlargement (SAVE) trial |
| spellingShingle |
Quality of life among patients post-myocardial infarction at baseline in the Survival and Ventricular Enlargement (SAVE) trial |
| ctrlnum |
(DE-627)NLEJ195670523 |
| title_full |
Quality of life among patients post-myocardial infarction at baseline in the Survival and Ventricular Enlargement (SAVE) trial |
| journal |
Quality of life research |
| journalStr |
Quality of life research |
| lang_code |
eng |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
1994 |
| contenttype_str_mv |
zzz |
| container_start_page |
111 |
| container_volume |
3 |
| physical |
9 |
| format_se |
Elektronische Aufsätze |
| title_sort |
quality of life among patients post-myocardial infarction at baseline in the survival and ventricular enlargement (save) trial |
| title_auth |
Quality of life among patients post-myocardial infarction at baseline in the Survival and Ventricular Enlargement (SAVE) trial |
| abstract |
Abstract A quality of life ancillary study was incorporated into the Survival and Ventricular Enlargement (SAVE) trial of captopril versus placebo among patients who survived an acute myocardial infarction with compromised ventricular functioning, but no overt heart failure. Assessments included patient symptoms, health perceptions, emotional, cognitive, social and sexual levels of functloning, as well as potential covariates, such as life events and social support. The purpose of this study was to evaluate the psychometric properties of the quality of life measures in the SAVE at baseline, and provide a pre-randomization profile of the SAVE patients. One hundred and eighty-four patients participated in this aspect of the trial. Reliability alpha coefficlents were adequate or better for all questionnaires, except for life events and sexual activities. Consistent with prior studies, the quality of life parameters were uncorrelated with ventricular ejection fraction. Despite experiencing a recent myocardial infarction with compromised ventricular functioning, patients at baseline generally nelther appeared depressed nor focused on symptoms. The baseline findings support the inclusion of the quality of life ancillary study in the overall SAVE trial because of the independent contribution likely to be achieved in terms of evaluating both disease progression and treatment efficacy. |
| abstractGer |
Abstract A quality of life ancillary study was incorporated into the Survival and Ventricular Enlargement (SAVE) trial of captopril versus placebo among patients who survived an acute myocardial infarction with compromised ventricular functioning, but no overt heart failure. Assessments included patient symptoms, health perceptions, emotional, cognitive, social and sexual levels of functloning, as well as potential covariates, such as life events and social support. The purpose of this study was to evaluate the psychometric properties of the quality of life measures in the SAVE at baseline, and provide a pre-randomization profile of the SAVE patients. One hundred and eighty-four patients participated in this aspect of the trial. Reliability alpha coefficlents were adequate or better for all questionnaires, except for life events and sexual activities. Consistent with prior studies, the quality of life parameters were uncorrelated with ventricular ejection fraction. Despite experiencing a recent myocardial infarction with compromised ventricular functioning, patients at baseline generally nelther appeared depressed nor focused on symptoms. The baseline findings support the inclusion of the quality of life ancillary study in the overall SAVE trial because of the independent contribution likely to be achieved in terms of evaluating both disease progression and treatment efficacy. |
| abstract_unstemmed |
Abstract A quality of life ancillary study was incorporated into the Survival and Ventricular Enlargement (SAVE) trial of captopril versus placebo among patients who survived an acute myocardial infarction with compromised ventricular functioning, but no overt heart failure. Assessments included patient symptoms, health perceptions, emotional, cognitive, social and sexual levels of functloning, as well as potential covariates, such as life events and social support. The purpose of this study was to evaluate the psychometric properties of the quality of life measures in the SAVE at baseline, and provide a pre-randomization profile of the SAVE patients. One hundred and eighty-four patients participated in this aspect of the trial. Reliability alpha coefficlents were adequate or better for all questionnaires, except for life events and sexual activities. Consistent with prior studies, the quality of life parameters were uncorrelated with ventricular ejection fraction. Despite experiencing a recent myocardial infarction with compromised ventricular functioning, patients at baseline generally nelther appeared depressed nor focused on symptoms. The baseline findings support the inclusion of the quality of life ancillary study in the overall SAVE trial because of the independent contribution likely to be achieved in terms of evaluating both disease progression and treatment efficacy. |
| collection_details |
GBV_USEFLAG_U ZDB-1-SOJ GBV_NL_ARTICLE |
| title_short |
Quality of life among patients post-myocardial infarction at baseline in the Survival and Ventricular Enlargement (SAVE) trial |
| url |
http://dx.doi.org/10.1007/BF00435254 |
| remote_bool |
true |
| author2 |
Gorkin, L. Follick, M. J. Geltman, E. Hamm, P. Sollano, J. S. Sylvia, S. Jacobson, K. Jacobson, M. J. Cochrane, B. S. Sussex, B. Klein, M. Gaudette, G. Goldman, D. Carrol, D. Holcombe, R. Abern, D. K. |
| author2Str |
Gorkin, L. Follick, M. J. Geltman, E. Hamm, P. Sollano, J. S. Sylvia, S. Jacobson, K. Jacobson, M. J. Cochrane, B. S. Sussex, B. Klein, M. Gaudette, G. Goldman, D. Carrol, D. Holcombe, R. Abern, D. K. |
| ppnlink |
NLEJ188989161 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth |
| up_date |
2024-07-06T04:23:23.212Z |
| _version_ |
1803802171892826112 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ195670523</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230506164050.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">070526s1994 xx |||||o 00| ||eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ195670523</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Quality of life among patients post-myocardial infarction at baseline in the Survival and Ventricular Enlargement (SAVE) trial</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1994</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract A quality of life ancillary study was incorporated into the Survival and Ventricular Enlargement (SAVE) trial of captopril versus placebo among patients who survived an acute myocardial infarction with compromised ventricular functioning, but no overt heart failure. Assessments included patient symptoms, health perceptions, emotional, cognitive, social and sexual levels of functloning, as well as potential covariates, such as life events and social support. The purpose of this study was to evaluate the psychometric properties of the quality of life measures in the SAVE at baseline, and provide a pre-randomization profile of the SAVE patients. One hundred and eighty-four patients participated in this aspect of the trial. Reliability alpha coefficlents were adequate or better for all questionnaires, except for life events and sexual activities. Consistent with prior studies, the quality of life parameters were uncorrelated with ventricular ejection fraction. Despite experiencing a recent myocardial infarction with compromised ventricular functioning, patients at baseline generally nelther appeared depressed nor focused on symptoms. The baseline findings support the inclusion of the quality of life ancillary study in the overall SAVE trial because of the independent contribution likely to be achieved in terms of evaluating both disease progression and treatment efficacy.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="f">Springer Online Journal Archives 1860-2002</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gorkin, L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Follick, M. J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Geltman, E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hamm, P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sollano, J. S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sylvia, S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jacobson, K.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jacobson, M. J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cochrane, B. S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sussex, B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Klein, M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gaudette, G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Goldman, D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Carrol, D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Holcombe, R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Abern, D. K.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">in</subfield><subfield code="t">Quality of life research</subfield><subfield code="d">1992</subfield><subfield code="g">3(1994) vom: Feb., Seite 111-119</subfield><subfield code="w">(DE-627)NLEJ188989161</subfield><subfield code="w">(DE-600)2008960-0</subfield><subfield code="x">1573-2649</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:3</subfield><subfield code="g">year:1994</subfield><subfield code="g">month:02</subfield><subfield code="g">pages:111-119</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1007/BF00435254</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-SOJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">3</subfield><subfield code="j">1994</subfield><subfield code="c">2</subfield><subfield code="h">111-119</subfield><subfield code="g">9</subfield></datafield></record></collection>
|
| score |
7.400985 |